New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

XLVvsVHTETF Comparison

ETF 1
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
-1.77%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
-1.77%

State Street Health Care Select Sector SPDR ETF (XLV) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. XLV's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Finance. In contrast, VHT's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.09% for VHT. XLV is up 16.06% year-to-date (YTD) with +$1.48B in YTD flows. VHT performs worse with 15.12% YTD performance, and +$540M in YTD flows. Run a side-by-side ETF comparison of XLV and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLV vs VHT performance and flow charts

Performance

0.02.04.06.08.0%Oct 19Oct 26Nov 2Nov 9Nov 16

Cumulative Flows

0 M500 M1,000 M1,500 MOct 19Oct 26Nov 2Nov 9Nov 16

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/19/2026
1M3MYTD1Y3Y5Y
Perf.
XLV
VHT
+1.05%+0.66%
+1.42%-0.16%
+16.06%+15.12%
+18.43%+17.53%
+44.59%+46.27%
+44.79%+38.76%
Flows
XLV
VHT
+$548M+$543M
+$715M+$491M
+$1.48B+$540M
+$1.15B+$675M
-$2.37B-$1.21B
+$3.14B-$650M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLV
VHT
+18.64%+18.30%
+17.19%+16.75%
+15.24%+15.12%
+15.46%+15.81%
Max drawdown
XLV
VHT
-6.43%-6.64%
-10.51%-10.39%
-17.05%-16.88%
-17.05%-17.77%
Max drawdown duration
XLV
VHT
15d15d
116d169d
444d435d
444d767d
Trading data

Create an account to view trading data

Join for free
XLV
VHT
Last sale
11/20/2026 at 3:41 PM
$179.54
$330.51
Previous close
11/19/2026
$177.46
$327.99
Consolidated volume
11/19/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XLV
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/20/2026 at 3:41 PM
Live
Closed
XLV
VHT
Last price
$179.54
$330.51
1D performance
+1.17%
+0.77%
AuM$46.92 B$20.24 B
E/R0.08%0.09%
Characteristics
XLV
VHT
Management strategyPassivePassive
ProviderState Street Investment ManagementVanguard
BenchmarkS&P Health Care Select Sector IndexMSCI US IMI Health Care 25/50 Index
N° of holdings61408
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 1998January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

XLV
USA
97.6%
Other
2.4%
VHT
USA
96.83%
Other
3.17%

Sectors

XLV
Healthcare
97.95%
Other
2.05%
VHT
Healthcare
97.77%
Other
2.23%
Advertisement

Diversification

XLV

Total weight of top 15 holdings out of 15

71.29%
VHT

Total weight of top 15 holdings out of 15

60.91%

Top 15 holdings

Data as of September 30, 2026
XLV
Eli Lilly & Co.
15.13%
Johnson & Johnson
10.43%
AbbVie, Inc.
7.55%
Merck & Co., Inc.
5.86%
UnitedHealth Group, Inc.
5.38%
Thermo Fisher Scientific, Inc.
4.08%
Amgen, Inc.
3.72%
Gilead Sciences, Inc.
3.02%
Abbott Laboratories
2.79%
Pfizer Inc.
2.66%
Intuitive Surgical, Inc.
2.35%
Danaher Corp.
2.27%
Vertex Pharmaceuticals, Inc.
2.17%
Bristol Myers Squibb Co.
2.08%
Medtronic Plc
1.81%
VHT
Eli Lilly & Co.
12.93%
Johnson & Johnson
8.78%
AbbVie, Inc.
6.45%
Merck & Co., Inc.
5.01%
UnitedHealth Group, Inc.
4.65%
Thermo Fisher Scientific, Inc.
3.50%
Amgen, Inc.
3.18%
Gilead Sciences, Inc.
2.58%
Abbott Laboratories
2.40%
Pfizer Inc.
2.27%
Intuitive Surgical, Inc.
2.01%
Danaher Corp.
1.97%
Vertex Pharmaceuticals, Inc.
1.85%
Bristol Myers Squibb Co.
1.78%
Medtronic Plc
1.54%
Frequently asked questions about XLV and VHT

How have the XLV and VHT ETFs performed in 2026?

As of November 19, 2026, XLV is up 16.06% year-to-date (YTD), while VHT has returned 15.12%. That puts XLV better performer ahead so far this year.

Which ETF is attracting more investor money: XLV or VHT?

Year-to-date, the XLV ETF saw +$1.48B in flows, compared to +$540M for VHT.

Which ETF is more volatile: XLV or VHT?

Over the past year, XLV had a volatility of 17.19%, while VHT experienced 16.75%.

Which ETF is bigger: XLV or VHT?

As of November 19, 2026, XLV holds $46.92 B in assets under management (AUM), while VHT manages $20.24 B.

What sectors do the XLV and VHT ETFs invest in?

XLV leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the XLV ETF and VHT ETF?

XLV top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: XLV or VHT?

XLV holds 61 securities with 71.29% of its assets in the top 15. VHT has 408 securities and a top 15 weight of 60.91%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026